-       Report 
- August 2025
-  186 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
            -       Report 
- May 2025
-  135 Pages 
- Global 
   From       €2268EUR$2,549USD£1,997GBP 
      €2669EUR$2,999USD£2,349GBP 
          -       Report 
- December 2024
-  137 Pages 
- Global 
   From       €3515EUR$3,950USD£3,094GBP 
            -       Report 
- October 2025
-  191 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
             -       Report 
- August 2025
-  189 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
          -       Report 
- December 2023
-  150 Pages 
- India 
   From       €5295EUR$5,950USD£4,661GBP 
          -       Report 
- July 2023
-  104 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
             The Large Volume Parenteral (LVP) market is a segment of the drug delivery industry that focuses on the delivery of large volumes of drugs and fluids intravenously. It is a critical component of the healthcare system, providing essential medications and fluids to patients in need. LVPs are typically used in the treatment of chronic and acute conditions, such as cancer, diabetes, and infectious diseases.
LVPs are typically administered through a variety of delivery systems, including syringes,    pumps, and bags. These systems are designed to ensure accurate and safe delivery of the drug or fluid. Additionally, LVPs are often used in combination with other drug delivery systems, such as inhalers and transdermal patches, to provide a comprehensive treatment plan.
The LVP market is highly competitive, with a number of companies offering a wide range of products and services. Some of the major players in the market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, and Pfizer. Show Less   Read more